
Sign up to save your podcasts
Or
There’s been an increase in the elderly irritable bowel disease (IBD) population, and it’s estimated that a third of our overall IBD population will soon be over the age of 60. When managing and diagnosing these patients, there’s different factors to consider, like polypharmacy, biological versus chronological age, how fit these patients are versus how frail they are, and more. To take a deep dive into how IBD is affecting elderly patients, join Dr. Peter Buch as he speaks with Dr. David Hudesman, Professor of Medicine and Co-director of NYU Langone’s Inflammatory Bowel Disease Center.
4.7
1818 ratings
There’s been an increase in the elderly irritable bowel disease (IBD) population, and it’s estimated that a third of our overall IBD population will soon be over the age of 60. When managing and diagnosing these patients, there’s different factors to consider, like polypharmacy, biological versus chronological age, how fit these patients are versus how frail they are, and more. To take a deep dive into how IBD is affecting elderly patients, join Dr. Peter Buch as he speaks with Dr. David Hudesman, Professor of Medicine and Co-director of NYU Langone’s Inflammatory Bowel Disease Center.
7 Listeners
69 Listeners
1 Listeners
3 Listeners
3 Listeners
0 Listeners
6 Listeners
14 Listeners
0 Listeners
2,433 Listeners
3,336 Listeners
111,917 Listeners
1,095 Listeners
3,364 Listeners
7,953 Listeners
185 Listeners
248 Listeners
249 Listeners
366 Listeners
33 Listeners
16 Listeners
11 Listeners